Long-Term Phosphodiesterase 5 Inhibitor Use Is Safe and Improves Symptoms in Patients with Pre-Capillary Pulmonary Hypertension of Sickle Cell Disease

被引：0
|
作者：
Cramer-Bour, C. [1 ]
Ruopp, N. [2 ]
Emeh, R. [3 ]
Ruhl, A. [4 ]
Weir, N. A. [5 ]
Thein, S. [4 ]
Nouraie, S. [6 ]
Klings, E. S. [7 ]
机构：
[1] Boston Univ, Pulm, Boston, MA 02215 USA
[2] Brigham & Womens Hosp, Pulm Crit Care, 75 Francis St, Boston, MA 02115 USA
[3] Howard Univ, Washington, DC 20059 USA
[4] NIAID, NIH, 9000 Rockville Pike, Bethesda, MD 20892 USA
[5] Fed Drug Adm, Rockville, MD USA
[6] Univ Pittsburgh, Med, PACCM, Pittsburgh, PA USA
[7] Boston Univ, Sch Med, Pulm Ctr Houseman R304, Boston, MA USA
来源：
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE | 2020年 / 201卷
关键词：
D O I：
暂无
中图分类号：
R4 [临床医学];
学科分类号：
1002 ; 100602 ;
摘要：
A7218
引用
收藏
页数：2
相关论文
共 50 条
  • [1] Long-term tolerability of phosphodiesterase-5 inhibitors in pulmonary hypertension of sickle cell disease
    Cramer-Bour, Cassondra
    Ruhl, Amy Parker
    Nouraie, Seyed Mehdi
    Emeh, Robert O.
    Ruopp, Nicole F.
    Thein, Swee Lay
    Weir, Nargues A.
    Klings, Elizabeth S.
    EUROPEAN JOURNAL OF HAEMATOLOGY, 2021, 107 (01) : 54 - 62
  • [2] Phosphodiesterase-5 inhibitor in pulmonary hypertension due to left heart disease with pre-capillary component: hemodynamic and functional impact
    Ramalho, A.
    Leao, S.
    Baptista, R.
    Prieto, D.
    Costa, S.
    Franco, F.
    Antunes, M.
    Pego, M.
    EUROPEAN HEART JOURNAL, 2014, 35 : 499 - 499
  • [3] Long-term survival outcome for pre-capillary pulmonary hypertension at a Japanese single center
    Sugiyama, Yoichi
    Tahara, Nobuhiro
    Bekki, Munehisa
    Tahara, Atsuko
    Honda, Akihiro
    Maeda-Ogata, Shoko
    Sun, Jiahui
    Igata, Sachiyo
    Fukumoto, Yoshihiro
    CANADIAN JOURNAL OF PHYSIOLOGY AND PHARMACOLOGY, 2020, 98 (09) : 644 - 652
  • [4] IMPACT OF PROLONGED NOCTURNAL HYPOXEMIA ON LONG-TERM CLINICAL OUTCOMES IN PATIENTS WITH PRE-CAPILLARY PULMONARY HYPERTENSION
    Huang, Zhihua
    Liu, Zhihong
    Luo, Qin
    Zhao, Zhihui
    Zhao, Qing
    Zhang, Yi
    Li, Xin
    Duan, Anqi
    Hu, Meixi
    JOURNAL OF HYPERTENSION, 2023, 41 : E282 - E282
  • [5] Phosphodiesterase 5 Inhibitor Therapy Improves Clinical Parameters in Patients With Heart Failure With Preserved Ejection Fraction and Combined Post- and Pre-capillary Pulmonary Hypertension
    Kramer, Tilmann T.
    Orlova, Kristina
    Gerhardt, Felix
    Dumitrescu, Daniel
    ten-Freyhaus, Henrik
    Baldus, Stephan
    Rosenkranz, Stephan
    CIRCULATION, 2017, 136
  • [6] Chronic blood exchange transfusions in the management of pre-capillary pulmonary hypertension complicating sickle cell disease
    Turpin, Matthieu
    Chantalat-Auger, Christelle
    Parent, Florence
    Driss, Francoise
    Lionnet, Francois
    Habibi, Anoosha
    Maitre, Bernard
    Huertas, Alice
    Jais, Xavier
    Weatherald, Jason
    Montani, David
    Sitbon, Olivier
    Simonneau, Gerald
    Galacteros, Frederic
    Humbert, Marc
    Bartolucci, Pablo
    Savale, Laurent
    EUROPEAN RESPIRATORY JOURNAL, 2018, 52 (04)
  • [7] Biomarkers for the Diagnosis and Assessment of Disease Severity in Patients with pre-capillary pulmonary Hypertension
    Rososinska, K.
    Markwirth, P.
    Kaiser, R.
    Trudzinski, F.
    Weingard, B.
    Bals, R.
    Wilkens, H.
    PNEUMOLOGIE, 2024, 78 : S57 - S57
  • [8] GENETIC ASSOCIATION OF A MAPK8 EXPRESSION QUANTITATIVE TRAIT LOCUS WITH PRE-CAPILLARY PULMONARY HYPERTENSION IN SICKLE CELL DISEASE
    Zhang, X.
    Zhang, W.
    Desai, A.
    Saraf, S.
    Abbasi, T.
    Casanova, N.
    Kittles, R.
    Garcia, J.
    Machado, R.
    Gordeuk, V.
    Ma, S.
    Miasnikova, G.
    Sergueeva, A.
    Ammosova, T.
    Xu, M.
    Nekhai, S.
    Steinberg, M.
    Baldwin, C.
    Sebastiani, P.
    Prchal, J.
    JOURNAL OF INVESTIGATIVE MEDICINE, 2014, 62 (04) : 714 - 714
  • [9] Beneficial Effects of Pulmonary Vasodilators on Pre-Capillary Pulmonary Hypertension in Patients with Chronic Kidney Disease on Hemodialysis
    Kimuro, Keiji
    Hosokawa, Kazuya
    Abe, Kohtaro
    Masaki, Kohei
    Imakiire, Satomi
    Sakamoto, Takafumi
    Tsutsui, Hiroyuki
    LIFE-BASEL, 2022, 12 (06):
  • [10] Pulmonary hypertension in sickle cell disease: Cardiopulmonary evaluation and response to chronic phosphodiesterase 5 inhibitor therapy.
    Machado, RF
    Martyr, SE
    Anthi, A
    Kato, GJ
    Hunter, LA
    Coles, WA
    Nichols, JS
    Castro, OL
    Gladwin, MT
    BLOOD, 2004, 104 (11) : 71A - 71A
12345